Neurovascular device market size to reach usd 2.92 billion by 2024 anoxia meaning

November 2016 | report format: electronic (PDF)

The global neurovascular device market was valued at USD 1.62 billion in the year 2015 and is expected to reach a value of USD 2.92 billion by 2024, growing at a CAGR of 6.5% according to a new report by grand view research, inc.

Key factors driving the market growth include increase in patients suffering from cerebral vascular disorders mandating assistance of neurovascular devices such as cerebral embolization and aneurysm coils, implementation of advanced technological platforms in this field, and the favorable reimbursement policies across established markets such as the U.S., canada, U.K., germany, and japan.

The market is segmented on the basis of device type and respective therapeutic applications.Anoxia meaning the embolization coils are widely employed in the treatments of strokes and cerebral aneurysms. They are responsible for majority of market share in the device type segment. According to world health organization (WHO), strokes are the leading cause of disability and third cause of death across the world. Stroke therapeutic application segment accounts for the largest market as compared to others. In addition, according to the american heart association, nearly 5% of the population is currently suffering from the cerebral aneurysms. Aneurysms can cause moderate to severe brain damage depending upon the condition. Therefore, their treatment is contributing to the increased demand of these platforms.Anoxia meaning

The embolization and aneurysms coiling devices are minimally invasive and are employed in effectively treating the aneurysms. Several diseases can be treated with the help of a single coil however; the unusual cerebral aneurysms require several expensive coils. Due to the efficacy, the volume for these procedures has increased over the years. This trend will continue over the forecast period, thereby rendering the leading position for this segment in terms of revenue share. The stenting systems possess the potential to address complex natured aneurysms, which were untreatable in the past. Hence, the cerebral angioplasty and stenting systems will exhibit an impressive growth pattern during the forecast period.Anoxia meaning

Moreover, stryker corporation is a key leader in the neurovascular device market, owing to the strategic acquisition of complete neurovascular portfolio of boston scientific corporation in the year 2010. The other notable players in this industry include abbott laboratories, W.L. Gore associates, inc., micorport scientific corporation, and terumo corporation.

To request a sample copy or view summary of this report, click the link below:

Http://www.Grandviewresearch.Com/industry-analysis/neurovascular-devices-market

Further key findings from the study suggest:

Rising incidence of cerebral vascular disorders such as strokes (both ischemic and hemorrhagic), arterial stenosis, and brain aneurysms are primarily responsible for the high demand for neurovascular diseases.Anoxia meaning

On the basis of types, the market is segmented into embolization and aneurysms coils, stenting systems, neurothrombectomy and support devices. Among these, embolic coils are widely used owing to the safety and efficacy, followed by the stenting systems.

According to the therapeutic application of the device type, stroke accounts for the largest market share, reason being the leading cause of disability and third cause of deaths worldwide.

In addition, the rising geriatric population and increased life expectancy are causing an increase in the target patient population.

Grand view research has segmented the neurovascular device market by type, therapeutic application, and region:

Device type outlook (revenue, USD million; 2013 – 2024)

anoxia meaning

Cerebral embolization and aneurysm coiling devices

Embolic coils

Flow diversion devices

Liquid embolic agents

Cerebral angioplasty and stenting systems

Carotid artery stents

Embolic protection systems (distal filter devices, balloon occlusion devices)

Neurothrombectomy devices

Clot retrieval devices

Suction devices

Vascular snares

Support devices

Micro catheters

Micro guidewires

Therapeutic applications outlook (revenue, USD million; 2013 – 2024)

Stroke

Cerebral artery stenosis

Cerebral aneurysm

Others

Regional outlook (revenue, USD million; 2013 – 2024)

North america

U.S.

Canada

Europe

Germany

UK

Asia pacific

China

Japan

Latin america

Mexico

Brazil

MEA

• south africa